Acute effects of transdermal estradiol administration on plasma levels of nitric oxide in postmenopausal women
Acute effects of transdermal estradiol administration on plasma levels of nitric oxide in postmenopausal women
复制标题
DOI:
10.1016/s0015-0282(97)81857-2
复制
发表时间:
1997-01-01
影响因子:
6.7
通讯作者:
Schonauer, LM
中科院分区:
文献类型:
--
作者:
Cicinelli, E;Ignarro, LJ;Schonauer, LM
Objective: To investigate the acute effects of transdermal E(2) administration on nitric oxide (NO) plasma levels in postmenopausal women.Design: Randomized, placebo-controlled trial.Setting: Normal human volunteers in an academic research environment.Patient(s): Twenty healthy postmenopausal women.Intervention(s): Transdermal administration of 100 mu g/d E(2) Or placebo.Main Outcome Measure(s): Plasma concentrations of NO stable oxidation products and serum concentrations of E(2) were assessed before and 24 hours after the administration.Result(s): In the group treated with E(2) mean concentration of NO metabolites 24 hours after patch application (37.31 +/- 7.62 mu mol/L) resulted significantly higher than baseline (21.04 +/- 5.71 mu mol/L) and the control group (23.50 +/- 4.03 mu mol/L). The correlation between the mean percent increase in NO metabolites and absolute E(2) concentrations 24 hours after the E(2) administration was statistically significant.Conclusion(s): Transdermal administration of E(2) to healthy postmenopausal women increases the plasma levels of NO and this supports the hypothesis that a NO-related mechanism may contribute to the cardiovascular protective effect of estrogens in postmenopause.